BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31661587)

  • 1. Efficacy and harms of long-term opioid therapy in chronic non-cancer pain: Systematic review and meta-analysis of open-label extension trials with a study duration ≥26 weeks.
    Bialas P; Maier C; Klose P; Häuser W
    Eur J Pain; 2020 Feb; 24(2):265-278. PubMed ID: 31661587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].
    Häuser W; Bernardy K; Maier C
    Schmerz; 2015 Feb; 29(1):96-108. PubMed ID: 25503691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
    Sommer C; Welsch P; Klose P; Schaefert R; Petzke F; Häuser W
    Schmerz; 2015 Feb; 29(1):35-46. PubMed ID: 25376548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration].
    Welsch P; Sommer C; Schiltenwolf M; Häuser W
    Schmerz; 2015 Feb; 29(1):85-95. PubMed ID: 25376546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
    Schaefert R; Welsch P; Klose P; Sommer C; Petzke F; Häuser W
    Schmerz; 2015 Feb; 29(1):47-59. PubMed ID: 25376547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
    Petzke F; Welsch P; Klose P; Schaefert R; Sommer C; Häuser W
    Schmerz; 2015 Feb; 29(1):60-72. PubMed ID: 25503883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.
    Sommer C; Klose P; Welsch P; Petzke F; Häuser W
    Eur J Pain; 2020 Jan; 24(1):3-18. PubMed ID: 31705717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids for chronic osteoarthritis pain: An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks double-blind duration.
    Welsch P; Petzke F; Klose P; Häuser W
    Eur J Pain; 2020 Apr; 24(4):685-703. PubMed ID: 31876347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids for chronic low back pain: An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks of double-blind duration.
    Petzke F; Klose P; Welsch P; Sommer C; Häuser W
    Eur J Pain; 2020 Mar; 24(3):497-517. PubMed ID: 31823442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Opioids in chronic noncancer pain-are opioids different? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids of at least four week's duration].
    Lauche R; Klose P; Radbruch L; Welsch P; Häuser W
    Schmerz; 2015 Feb; 29(1):73-84. PubMed ID: 25376545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
    Petzke F; Enax-Krumova EK; Häuser W
    Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: A systematic review and meta-analysis of effectiveness and safety.
    Bialas P; Fitzcharles MA; Klose P; Häuser W
    Eur J Pain; 2022 Jul; 26(6):1221-1233. PubMed ID: 35467781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.
    Els C; Jackson TD; Kunyk D; Lappi VG; Sonnenberg B; Hagtvedt R; Sharma S; Kolahdooz F; Straube S
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012509. PubMed ID: 29084357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of strong opioids for chronic noncancer pain and chronic low back pain: a systematic review and meta-analyses.
    Nury E; Schmucker C; Nagavci B; Motschall E; Nitschke K; Schulte E; Wegwarth O; Meerpohl JJ
    Pain; 2022 Apr; 163(4):610-636. PubMed ID: 34326292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
    Zheng Y; Kostenbader K; Barrett T; Hisaw E; Giuliani MJ; Chen Y; Young JL
    Clin Ther; 2015 Jun; 37(6):1235-47. PubMed ID: 25913923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term opioid management for chronic noncancer pain.
    Noble M; Treadwell JR; Tregear SJ; Coates VH; Wiffen PJ; Akafomo C; Schoelles KM
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD006605. PubMed ID: 20091598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis.
    Abdel Shaheed C; Maher CG; Williams KA; Day R; McLachlan AJ
    JAMA Intern Med; 2016 Jul; 176(7):958-68. PubMed ID: 27213267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone for neuropathic pain in adults.
    McNicol ED; Ferguson MC; Schumann R
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012499. PubMed ID: 28514508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy for the treatment of chronic nonspecific low back pain: systematic review and meta-analysis.
    Chung JW; Zeng Y; Wong TK
    Pain Physician; 2013; 16(6):E685-704. PubMed ID: 24284847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.